Mal-amido-PEG7-acid manufacturers
- Mal-amido-PEG7-acid
-
- $0.00 / 1g
-
2024-03-27
- CAS:2112731-42-5
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| Mal-amido-PEG7-acid Basic information |
Product Name: | Mal-amido-PEG7-acid | Synonyms: | Mal-amido-PEG7-acid;Mal-NH-PEG7-acid;Mal-amido-PEG7-COOH;Mal-NH-PEG7-COOH;4,7,10,13,16,19,22-Heptaoxa-25-azaoctacosanoic acid, 28-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-26-oxo-;Mal-amido-PEG7-propionic acid;1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25-heptaoxa-4-azaoctacosan-28-oic acid;MalamidoPEG7acid,PROTAC Linkers,Mal amido PEG7 acid,inhibit,Inhibitor | CAS: | 2112731-42-5 | MF: | C24H40N2O12 | MW: | 548.58 | EINECS: | | Product Categories: | peg | Mol File: | 2112731-42-5.mol | |
| Mal-amido-PEG7-acid Chemical Properties |
| Mal-amido-PEG7-acid Usage And Synthesis |
Uses | Mal-amido-peg7-acid is a useful research chemical, a PEG linker and a PEG reagent. | Biological Activity | Mal-amido-PEG7-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| Mal-amido-PEG7-acid Preparation Products And Raw materials |
|